Foghorn therapeutics to participate at the 2021 wedbush pacgrow healthcare virtual conference

Cambridge, mass., aug. 03, 2021 (globe newswire) -- foghorn therapeutics inc. (nasdaq: fhtx), a company pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, today announced that steven bellon, ph.d., senior vice president of drug discovery, is scheduled to participate in a panel at the 2021 wedbush pacgrow healthcare virtual conference, which is being held from august 10-11.
FHTX Ratings Summary
FHTX Quant Ranking